image credit: The U.S. FDA / Wikimedia

FDA said to plan early December advisory meetings to discuss Covid-19 vaccines ahead of potential authorization

November 18, 2020


The Food and Drug Administration has asked a group of advisors to set aside three days in early December for potential meetings to discuss Covid-19 vaccines — a key step in the agency’s authorization process, according to two people familiar with the plans.

The advisory group may be asked to weigh in on Pfizer and Moderna’s vaccines, said the people, who asked not to be named because the plans aren’t yet public.

The meetings, tentatively set for Dec. 8-10, would come just weeks after both companies reported data from their phase three trials showing their vaccines are about 95% effective in preventing cases of Covid-19.

Read More on CNBC